FY2024 EPS Estimates for Option Care Health, Inc. Lifted by Analyst (NASDAQ:OPCH)

Option Care Health, Inc. (NASDAQ:OPCH) – Investment analysts at Barrington Research raised their FY2024 EPS estimates for Option Care Health in a research note issued on Wednesday, April 24th. Barrington Research analyst M. Petusky now forecasts that the company will earn $1.15 per share for the year, up from their previous forecast of $1.10. Barrington Research has a “Outperform” rating and a $38.00 price target on the stock. The consensus estimate for Option Care Health’s current full-year earnings is $1.17 per share. Barrington Research also issued estimates for Option Care Health’s FY2025 earnings at $1.35 EPS.

Separately, Jefferies Financial Group increased their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a report on Monday, March 4th.

Option Care Health Stock Performance

Shares of NASDAQ:OPCH opened at $29.29 on Friday. The business has a fifty day moving average of $32.04 and a 200-day moving average of $31.50. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.33 and a current ratio of 1.77. Option Care Health has a twelve month low of $24.23 and a twelve month high of $35.74. The firm has a market cap of $5.09 billion, a PE ratio of 19.27, a price-to-earnings-growth ratio of 1.65 and a beta of 1.22.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Tuesday, April 23rd. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.04. The company had revenue of $1.15 billion during the quarter, compared to analyst estimates of $1.10 billion. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. The company’s revenue was up 12.8% on a year-over-year basis. During the same quarter last year, the business posted $0.21 earnings per share.

Institutional Investors Weigh In On Option Care Health

Several large investors have recently made changes to their positions in OPCH. IFP Advisors Inc raised its stake in shares of Option Care Health by 20,350.0% during the 3rd quarter. IFP Advisors Inc now owns 2,454 shares of the company’s stock worth $79,000 after purchasing an additional 2,442 shares in the last quarter. State of Alaska Department of Revenue raised its holdings in shares of Option Care Health by 4.3% during the 3rd quarter. State of Alaska Department of Revenue now owns 21,376 shares of the company’s stock worth $691,000 after buying an additional 880 shares in the last quarter. Exchange Traded Concepts LLC acquired a new position in Option Care Health during the 3rd quarter worth approximately $812,000. Handelsbanken Fonder AB raised its position in Option Care Health by 24.3% in the third quarter. Handelsbanken Fonder AB now owns 33,300 shares of the company’s stock valued at $1,077,000 after purchasing an additional 6,500 shares during the last quarter. Finally, Sheets Smith Wealth Management lifted its holdings in shares of Option Care Health by 1.6% during the third quarter. Sheets Smith Wealth Management now owns 32,542 shares of the company’s stock worth $1,053,000 after purchasing an additional 510 shares during the period. Institutional investors own 98.05% of the company’s stock.

Insider Activity

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 35,000 shares of Option Care Health stock in a transaction dated Monday, February 26th. The shares were bought at an average price of $31.55 per share, with a total value of $1,104,250.00. Following the purchase, the director now owns 269,528 shares of the company’s stock, valued at $8,503,608.40. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.64% of the stock is currently owned by insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.